Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 3751 AL 3765

Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging

Massa J, Chahine LM.

J Parkinsons Dis. 2019;9(2):327-334. doi: 10.3233/JPD-181517.

Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial

Kwok JYY, Kwan JCY, Auyeung M, Mok VCT, Lau CKY, Choi KC, Chan HYL.

JAMA Neurol. 2019 Jul 1;76(7):755-763. doi: 10.1001/jamaneurol.2019.0534.

Will genotype drive treatment options?

Brüggemann N, Klein C.

Mov Disord. 2019 Sep;34(9):1294-1299. doi: 10.1002/mds.27699. Epub 2019 Apr 10.

Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics

Savitt D, Jankovic J.

Drugs. 2019 Jun;79(8):797-810. doi: 10.1007/s40265-019-01104-1.

Extensive validation study of the Parkinson's Disease Composite Scale

Martinez-Martin P, Radicati FG, Rodriguez Blazquez C, Wetmore J, Kovacs N, Ray Chaudhuri K, Stocchi F; PDCS European Study Group.

Eur J Neurol. 2019 Oct;26(10):1281-1288. doi: 10.1111/ene.13976. Epub 2019 May 31.

Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson's disease: A single-arm, open-label, prospective, multicenter study

Iijima M, Orimo S, Terashi H, Suzuki M, Hayashi A, Shimura H, Mitoma H, Kitagawa K, Okuma Y.

Expert Opin Pharmacother. 2019 Aug;20(11):1405-1411. doi: 10.1080/14656566.2019.1614167. Epub 2019 May 28.

MDS evidence-based review of treatments for essential tremor

Ferreira JJ, Mestre TA, Lyons KE, Benito-León J, Tan EK, Abbruzzese G, Hallett M, Haubenberger D, Elble R, Deuschl G; MDS Task Force on Tremor and the MDS Evidence Based Medicine Committee.

Mov Disord. 2019 Jul;34(7):950-958. doi: 10.1002/mds.27700. Epub 2019 May 2.

Clinical and methodological challenges for assessing freezing of gait: Future perspectives

Mancini M, Bloem BR, Horak FB, Lewis SJG, Nieuwboer A, Nonnekes J.

Mov Disord. 2019 Jun;34(6):783-790. doi: 10.1002/mds.27709. Epub 2019 May 2.

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort

Regnault A, Boroojerdi B, Meunier J, Bani M, Morel T, Cano S.

J Neurol. 2019 Aug;266(8):1927-1936. doi: 10.1007/s00415-019-09348-3. Epub 2019 May 9.

ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson's Disease

Tamplin J, Morris ME, Marigliani C, Baker FA, Vogel AP.

Neurorehabil Neural Repair. 2019 Jun;33(6):453-463. doi: 10.1177/1545968319847948. Epub 2019 May 12.

Tremor

Saifee TA.

Br Med Bull. 2019 Jun 19;130(1):51-63. doi: 10.1093/bmb/ldz017.

Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade

Marras C, Canning CG, Goldman SM.

Mov Disord. 2019 Jun;34(6):801-811. doi: 10.1002/mds.27720. Epub 2019 May 15.

Leksell Radiosurgery for Movement Disorders

Niranjan A, Raju SS, Lunsford LD.

Prog Neurol Surg. 2019;34:279-288. doi: 10.1159/000493075. Epub 2019 May 16.

Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis

Saredakis D, Collins-Praino LE, Gutteridge DS, Stephan BCM, Keage HAD.

Parkinsonism Relat Disord. 2019 Aug;65:20-31. doi: 10.1016/j.parkreldis.2019.04.020. Epub 2019 May 7.

Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)

Peball M, Werkmann M, Ellmerer P, Stolz R, Valent D, Knaus HG, Ulmer H, Djamshidian A, Poewe W, Seppi K.

J Neural Transm (Vienna). 2019 Aug;126(8):1061-1072. doi: 10.1007/s00702-019-02021-z. Epub 2019 May 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias